Cargando…
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort
BACKGROUND AND AIMS: In moving towards the elimination of hepatitis C virus (HCV) infection among people living with HIV, understanding HCV transmission patterns may provide insights to guide and evaluate interventions. In this study, we evaluated patterns of, and factors associated with HCV phyloge...
Autores principales: | Bartlett, Sofia R., Verich, Andrey, Carson, Joanne, Hosseini‐Hooshyar, Samira, Read, Phillip, Baker, David, Post, Jeffrey J., Finlayson, Robert, Bloch, Mark, Doyle, Joseph S., Shaw, David, Hellard, Margaret, Martinez, Maria, Marks, Philippa, Dore, Gregory J., Matthews, Gail V., Applegate, Tanya, Martinello, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388196/ https://www.ncbi.nlm.nih.gov/pubmed/36000082 http://dx.doi.org/10.1002/hsr2.719 |
Ejemplares similares
-
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Martinello, Marianne, et al.
Publicado: (2016) -
Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study
por: Hosseini‐Hooshyar, Samira, et al.
Publicado: (2022) -
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial
por: Grebely, Jason, et al.
Publicado: (2020) -
A latent class approach to identify multi‐risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015
por: Bartlett, Sofia R, et al.
Publicado: (2019) -
High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study
por: Yee, Jasmine, et al.
Publicado: (2021)